DDD · 3D Systems Corporation

The thesis

3D Systems' recovery case is still unproven and the shares are more likely to lag the S&P 500 than lead it over the next three months; the Q3 2026 report, expected in early November and not yet dated by the company, settles whether revenue of $96 million–$99 million and a narrower loss arrive. The adjusted close on 22 October 2026 was $3.05, equal to the price of the June 2026 stock offering and 21.4% below the 52-week high of $3.88.

The narrative is maturing: the latest company news is a new industrial technology center in Littleton, Colorado (21 October 2026) and a placement in a 3D printing platforms customer-success report (21 October 2026). Neither is a revenue event. The 14-day relative strength index (a 0–100 momentum gauge) was 25.5 on 22 October 2026, a level usually read as oversold. The three-month price change is +16.0%, so the shares are still higher than in July even after the October drop.

Bullish and bearish views on 3D Systems Corporation

The bull case on 3D Systems Corporation (DDD), in brief: Guidance sits above analyst estimates. The bear case: The company is still unprofitable.

Bull case

• Guidance sits above analyst estimates. On 3 August 2026 3D Systems guided Q3 revenue to $96 million–$99 million against a $93.787 million estimate cited by Benzinga. Q2 revenue of $94.579 million and an adjusted loss of $0.04 per share beat estimates of $93.761 million and $0.05.
• Healthcare is growing. Healthcare Solutions revenue was $48.1 million in Q2 2026, up 6.8% from a year earlier, per the 3 August 2026 results release. The FDA premarket clearance for the 3D Mac titanium cranial plate system, announced 28 July 2026, adds a product to that segment.
• Defense funding is disclosed. A further $9 million Air Force award on 10 August 2026 extended the large-format metal printer demonstrator program by two years and lifted total funding to $27.4 million.
• Analysts see room above the price. MarketBeat reported on 4 August 2026 that Craig Hallum upgraded the shares to buy with a $6.00 target, and listed an average analyst target of $5.50 in early September. Both sit well above the $3.05 close.

Bear case

• The company is still unprofitable. The Q3 adjusted EBITDA (earnings before interest, taxes, depreciation and amortization) guide is a loss of $1 million–$3 million, following a Q2 loss of $0.8 million per the 3 August 2026 release.
• Printer sales compressed margins. Q2 gross margin was 36.4%, against 38.1% a year earlier, and the company attributed part of the pressure to higher printer sales.
• The shares have returned to the offering price. The company issued 18.9 million common shares in Q2 2026 for $53.2 million net of offering costs, per the 3 August 2026 release. The adjusted close fell from $3.38 on 9 October 2026 to $3.05 on 22 October 2026, the June offering price.
• The chief executive is leaving. On 4 August 2026 the company said Jeffrey Graves will retire and stay until a successor is named, expected later in 2026. No successor had been announced in company news through 22 October 2026.

Price setup

The adjusted close on 22 October 2026 was $3.05. The 52-week high of $3.88 is 21.4% above it. The close sits exactly on the $3.05 June 2026 offering price, the level that anchors the invalidation condition below.

The fall to an RSI of 25.5 came without a company announcement that explains it. Crowding evidence is thin: no insider transactions or new filings appear in the past 30 days, and the main dated event ahead is the earnings report. Last year the company announced its Q3 date on 30 October 2025 for a report on 4 November 2025, so a similar notice is likely in the coming week.

Catalysts, next 30 days

• Later in 2026, undated. Announcement of a successor chief executive, which the company has said it expects this year.

Elapsed catalysts

• ~30 October 2026, est. Company notice of the Q3 2026 report date. In 2025 the notice came about five days before the report. (passed 7d ago)
• ~3 November 2026, est. Q3 2026 earnings release. The company has not confirmed the date; some calendars show earlier. It tests the $96 million–$99 million revenue guide and the $1 million–$3 million adjusted EBITDA loss guide. (passed 3d ago)

What would change the view

The case breaks if Q3 2026 revenue comes in below the $96 million low end of guidance, or if the adjusted EBITDA loss is wider than $3 million. A daily close below $2.90 would put the shares under the $3.05 June 2026 offering price with room to spare and show that buyers are not defending it. A successor announcement that comes with a strategy change would also reset the frame.

Evidence that would lift the rating: Q3 revenue at or above $99 million with gross margin back above the 38.1% of a year ago, or a first adjusted EBITDA profit.

What it trades with

3D Systems trades with small-cap industrial technology and 3D printing peers, and its sales depend on customers' capital spending on printers. Roughly half of Q2 revenue came from Healthcare Solutions ($48.1 million of $94.6 million), which follows medical-device demand more than factory spending. The Air Force and hypersonic-parts announcements tie part of the story to US defense budgets, though none has yet appeared as recognised revenue in a quarterly report.